Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$466M |
| 2 |
Applovin
APP
|
+$349M |
| 3 |
General Dynamics
GD
|
+$272M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$257M |
| 5 |
iShares Global Infrastructure ETF
IGF
|
+$222M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ANSS
Ansys
ANSS
|
+$396M |
| 2 |
HES
Hess
HES
|
+$383M |
| 3 |
Apple
AAPL
|
+$362M |
| 4 |
NVIDIA
NVDA
|
+$298M |
| 5 |
Microsoft
MSFT
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.46% |
| 2 | Financials | 12.23% |
| 3 | Consumer Discretionary | 9.45% |
| 4 | Communication Services | 8.8% |
| 5 | Healthcare | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4351
Lisata Therapeutics
LSTA
$9.02M
| $26.9K | ﹤0.01% |
10,268
| – | – |
|
4352
Femasys
FEMY
$8.64M
| $26.6K | ﹤0.01% |
3,768
+1,091
| +41% | +$14.2K |
|
4353
IRIDEX
IRIX
$14.3M
| $26.5K | ﹤0.01% |
23,259
-1,646
| -7% | -$2.02K |
|
|
RVPH
4354
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
| $26.3K | ﹤0.01% |
3,569
| – | – |
|
4355
FibroBiologics
FBLG
$4.26M
| $26K | ﹤0.01% |
2,384
-22
| -0.9% | -$263 |
|
|
VEEA
4356
Veea Inc
VEEA
$8.34M
| $25.4K | ﹤0.01% |
40,750
+13,158
| +48% | +$14K |
|
4357
Elutia
ELUT
$37.9M
| $24.6K | ﹤0.01% |
27,662
| – | – |
|
4358
Sidus Space
SIDU
$171M
| $23.6K | ﹤0.01% |
22,685
| – | – |
|
4359
Fractyl Health
GUTS
$109M
| $23.3K | ﹤0.01% |
14,640
| – | – |
|
4360
Drilling Tools International
DTI
$82.6M
| $23.1K | ﹤0.01% |
10,030
| – | – |
|
4361
Stran & Co
SWAG
$36.7M
| $23K | ﹤0.01% |
13,861
| – | – |
|
4362
Senti Biosciences Holdings
SNTI
$10.6M
| $23K | ﹤0.01% |
+16,310
| New | +$27.3K |
|
4363
SAB Biotherapeutics
SABS
$273M
| $22.9K | ﹤0.01% |
11,387
| – | – |
|
|
SOHO
4364
DELISTED
Sotherly Hotels
SOHO
| $22.9K | ﹤0.01% |
28,607
-734
| -3% | -$612 |
|
4365
Cosmos Holdings
COSM
$13.4M
| $22.8K | ﹤0.01% |
20,554
| – | – |
|
4366
Smith Micro Software
SMSI
$14.5M
| $22.4K | ﹤0.01% |
6,203
| – | – |
|
4367
Nexalin Technology
NXL
$7.44M
| $22.1K | ﹤0.01% |
24,100
| – | – |
|
4368
Dawson Geophysical
DWSN
$145M
| $21.8K | ﹤0.01% |
12,374
| – | – |
|
4369
CXApp
CXAI
$13.4M
| $21.4K | ﹤0.01% |
29,013
| – | – |
|
|
SGRP
4370
DELISTED
SPAR Group
SGRP
| $20.8K | ﹤0.01% |
20,180
| – | – |
|
4371
Expion360
XPON
$3.44M
| $20.6K | ﹤0.01% |
+1,192
| New | +$18.7K |
|
4372
Envoy Medical
COCH
$51.7M
| $20.5K | ﹤0.01% |
26,389
+12,346
| +88% | +$16.7K |
|
4373
Good Times Restaurants
GTIM
$14.6M
| $20.4K | ﹤0.01% |
12,529
| – | – |
|
4374
PAVmed
PAVM
$35.4M
| $20K | ﹤0.01% |
1,550
+1,160
| +297% | +$17.2K |
|
|
ZEO
4375
Zeo Energy
ZEO
$17.7M
| $19.8K | ﹤0.01% |
+14,663
| New | +$29.6K |
|
Similar funds
Northern Trust's Q3 2025 Portfolio in Review
As of Q3 2025, Northern Trust held 4,566 positions worth $782B, up 7.5% from $727B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Northern Trust's Q3 2025 filing shows 167 new, 1,770 increased, 2,268 reduced and 144 closed positions. Its largest new stake was Amrize Ltd: 1,020,799 shares worth $49.5M. The largest sale was Ansys, an estimated $396M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.
- Northern Trust's largest Q3 2025 buy was Amrize Ltd: 1,020,799 shares worth $49.5M.
- Northern Trust added most to Chevron in Q3 2025, an estimated $466M increase.
- Northern Trust's biggest Q3 2025 reduction was Apple, cutting an estimated $362M.
- Northern Trust fully exited Ansys in Q3 2025, selling an estimated $396M.
- Northern Trust's ten largest holdings make up 30% of its $782B portfolio in Q3 2025.
- Northern Trust opened 167 new positions and closed 144 in Q3 2025.
- Northern Trust's portfolio value rose 7.5% quarter-over-quarter to $782B.
Based on Northern Trust's 13F filing for Q3 2025, filed 14 Nov 2025.